InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: PLX-11 post# 17519

Friday, 10/26/2018 3:41:53 PM

Friday, October 26, 2018 3:41:53 PM

Post# of 44784
Thanks for the reply. Agreed on all but one front. Would add a few things as well.

Not the best timing to try and get a partner on your terms with financing dwindling quickly. Potential partners are obviously not in any rush. No bidding wars here. They would have a pretty good idea of Pluristem’s situation. Some pretty smart people running these companies. We have wannabes. Going it alone has proved to be a big mistake so far. They have been holding out for years, and may just suck it up and take anything out of necessity. Gets worse and worse with each passing quarter. Hence Widestream

There’s a reason nobody looks for reimbursement from EAP. Want to keep actual manufacturing costs hidden. We had “sales” one quarter for $50 g’s with a cogs at $2’s. Hopefully our experienced management doesn’t get burned on that one. But desperate times call for desperate measures.

Really don’t have faith in our patents. Just search bioreactors, 3D bioreactors. They exist. One would think in direct violation of our patents. But who knows. Certainly don’t have the cash to test that.

And yes, I think that’s the only positive when it comes to Celularity.

You could add a few to the negative column. Experienced. Well connected. And the big one, they don’t have Zami his sidekick accountant steering the ship. Wonder if Kaki ever used the “solution in my pocket” walking in to a meeting with a potential partner. Wouldn’t surprise me in the least.

Scary competitor indeed.